Literature DB >> 9680238

Structural determinants of the blocker binding site in glutamate and NMDA receptor channels.

A V Ferrer-Montiel1, J M Merino, R Planells-Cases, W Sun, M Montal.   

Abstract

Glutamate receptor channels of the NMDA-type (N-methyl-D-aspartate) and non-NMDA-type (GluR) differ in their pore properties. The N-site in the M2 transmembrane segment of NMDA receptors (NMDAR), or the corresponding Q/R-site in GluRs, is a pivotal structural determinant of their permeation and blockade characteristics. Substitutions at a second site in M2, the L-site (L577) in GluR1, drastically alter the receptor selectivity to divalent cations. Here we report that M2 mutants carrying an asparagine or a threonine residue at the Q-site of GluR1, along with a tryptophan residue at the L-site, form homomeric GluR1 channels that are highly sensitive to structurally diverse, uncompetitive NMDA antagonists such as arylcyclohexylamines, dibenzocycloheptenimines, and to morphinian and adamantane derivatives. Analysis of the voltage dependence of channel blockade locates the blocker binding site approximately 0.65 partway into the transmembrane electric field in both GluR1 mutants and NMDAR channels. Our results suggest that the homomeric GluR1 double mutants, L577W/Q582N and L577W/Q582T, fairly approximate the pore properties of the heteromeric NMDA receptor and support the structural kinship of their permeation pathways.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9680238     DOI: 10.1016/s0028-3908(98)00007-0

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  10 in total

1.  Voltage-dependent block of native AMPA receptor channels by dicationic compounds.

Authors:  D B Tikhonov; M V Samoilova; S L Buldakova; V E Gmiro; L G Magazanik
Journal:  Br J Pharmacol       Date:  2000-01       Impact factor: 8.739

2.  Structural characteristics of ionotropic glutamate receptors as identified by channel blockade.

Authors:  L G Magazanik; K V Bol'shakov; S L Buldakova; V E Gmiro; N A Dorofeeva; N Ya Lukomskaya; N N Potap'eva; M V Samoilova; D B Tikhonov; I M Fedorova; E V Frolova
Journal:  Neurosci Behav Physiol       Date:  2002 Mar-Apr

3.  Studies of the structure of glutamate receptor ion channels and the mechanisms of their blockade by organic cations.

Authors:  L G Magazanik; D B Tikhonov; K V Bol'shakov; V E Gmiro; S L Buldakova; M V Samoilova
Journal:  Neurosci Behav Physiol       Date:  2003-03

4.  Differential binding properties of [3H]dextrorphan and [3H]MK-801 in heterologously expressed NMDA receptors.

Authors:  K T LePage; J E Ishmael; C M Low; S F Traynelis; T F Murray
Journal:  Neuropharmacology       Date:  2005-04-01       Impact factor: 5.250

5.  An N-methyl-D-aspartate receptor channel blocker with neuroprotective activity.

Authors:  K K Tai; S E Blondelle; J M Ostresh; R A Houghten; M Montal
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

6.  Modeling of the pore domain of the GLUR1 channel: homology with K+ channel and binding of channel blockers.

Authors:  Denis B Tikhonov; Jan R Mellor; Peter N R Usherwood; Lev G Magazanik
Journal:  Biophys J       Date:  2002-04       Impact factor: 4.033

7.  Attenuation of thermal nociception and hyperalgesia by VR1 blockers.

Authors:  Carolina García-Martinez; Marc Humet; Rosa Planells-Cases; Ana Gomis; Marco Caprini; Felix Viana; Elvira De La Pena; Francisco Sanchez-Baeza; Teresa Carbonell; Carmen De Felipe; Enrique Pérez-Paya; Carlos Belmonte; Angel Messeguer; Antonio Ferrer-Montiel
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-19       Impact factor: 11.205

8.  Intersegment hydrogen bonds as possible structural determinants of the N/Q/R site in glutamate receptors.

Authors:  D B Tikhonov; B S Zhorov; L G Magazanik
Journal:  Biophys J       Date:  1999-10       Impact factor: 4.033

Review 9.  Contributions of experimental psychiatry to research on the psychosis prodrome.

Authors:  Mitja Bodatsch; Joachim Klosterkötter; Jörg Daumann
Journal:  Front Psychiatry       Date:  2013-12-17       Impact factor: 4.157

10.  Pharmacodynamics of memantine: an update.

Authors:  G Rammes; W Danysz; C G Parsons
Journal:  Curr Neuropharmacol       Date:  2008-03       Impact factor: 7.363

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.